As of 2025-05-25, the Gross Margin of Strongbridge Biopharma plc (SBBP) is 92.8%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2020-12-31 | 92.8% |
2019-12-31 | 82.4% |
2018-12-31 | 77.9% |
2017-12-31 | 78.9% |
2016-12-31 | - |
2015-12-31 | - |
2014-12-31 | - |
2013-12-31 | - |
- | |
- |